The course of gastric cancer following surgery is associated with genetic variations of the interleukin-1 receptor antagonist and interleukin-1ß.

van der Ploeg, Anke H; Kumpf, Oliver; Seelow, Evelyn; Almanza, Luis C Berrocal; Schlag, Peter M; Schumann, Ralf R; Hamann, Lutz

van der Ploeg, Anke H; Kumpf, Oliver; Seelow, Evelyn; Almanza, Luis C Berrocal; Schlag, Peter M; Schumann, Ralf R; Hamann, Lutz.

Affiliation

van der Ploeg AH; Institute for Microbiology and Hygiene, Charité University Medicine Berlin, Hindenburgdamm 27, 12203, Berlin, Germany.

Gastric Cancer ; 18(1): 77-83, 2015 Jan.

Article in En | MEDLINE | ID: mdl-24557417

Subject(s)

Interleukin 1 Receptor Antagonist Protein/genetics; Interleukin-1beta/genetics; Stomach Neoplasms/genetics; Stomach Neoplasms/surgery; Aged; Cohort Studies; Disease-Free Survival; Female; Heterozygote; Humans; Male; Middle Aged; Minisatellite Repeats; Polymorphism, Single Nucleotide; Retrospective Studies; Stomach Neoplasms/mortality; Stomach Neoplasms/pathology; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Interleukin 1 Receptor Antagonist Protein / Interleukin-1beta Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2015 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google